Clinical Protein Science and Imaging, Department of Biomedical Engineering, Lund University, Lund, Sweden; Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, Sweden; Biofilms -Research Center for Biointerfaces, Malmö University, Malmö, Sweden.
Clinical Protein Science and Imaging, Department of Biomedical Engineering, Lund University, Lund, Sweden; Laboratory of Veterinary Pathology, School of Veterinary Medicine, Azabu University, Sagamihara, Kanagawa, Japan.
J Pharm Biomed Anal. 2019 Feb 5;164:9-15. doi: 10.1016/j.jpba.2018.10.013. Epub 2018 Oct 7.
Reproducible quantification of drug transporter protein expression in tissues is important for predicting transporter mediated drug disposition. Many mass-spectrometry based transporter protein quantification methods result in high variability of the estimated transporter quantities. Therefore, we aimed to evaluate and optimize mass spectrometry-based quantification method for drug transporter proteins in tissues.
Plasma membrane (PM) proteins from mouse tissues were isolated by applying three extraction protocols: commercial plasma membrane extraction kit, tissue homogenization by Potter-Elvehjem homogenizer in combination with sucrose-cushion ultracentrifugation, and PM enrichment with Tween 40. Moreover, five different protein digestion protocols were applied on the same PM fraction. PM isolation and digestion protocols were evaluated by measuring the amount of transporter proteins by liquid chromatography-tandem mass spectrometry in selected reaction monitoring mode.
Mouse liver homogenization by Potter-Elvehjem homogenizer in combination with sucrose-cushion ultracentrifugation and PM enrichment with Tween 40 resulted in two times higher transporter protein quantity (Breast cancer resistance protein (Bcrp) 18.0 fmol/μg protein) in comparison with the PM samples isolated by extraction kit (Bcrp 9.8 fmol/μg protein). The evaluation of protein digestion protocols revealed that the most optimal protocol for PM protein digestion is with Lys-C and trypsin, in combination with trypsin enhancer and heat denaturation. Overall, quantities of Bcrp and Na+/K + ATPase proteins evaluated in mouse liver and kidney cortex by using our optimized PM isolation method, as well as, established digestion protocol were two to three times higher than previously reported and coefficient of variation (CV) for technical replicates was below 10%.
We have established an improved transporter protein quantification methodology by optimizing PM isolation and protein digestion procedures. The optimized procedure resulted in a higher transporter protein yield and improved precision.
在组织中重现药物转运蛋白表达的定量对于预测转运体介导的药物处置非常重要。许多基于质谱的转运蛋白定量方法导致估计的转运体数量的高度变异性。因此,我们旨在评估和优化基于质谱的组织中药物转运蛋白定量方法。
通过应用三种提取方案:商业质膜提取试剂盒、Potter-Elvehjem 匀浆器与蔗糖垫超速离心相结合的组织匀浆以及 Tween 40 的质膜富集,从鼠组织中分离质膜(PM)蛋白。此外,还应用了五种不同的蛋白消化方案对同一 PM 级分进行了研究。通过液相色谱-串联质谱在选择反应监测模式下测量转运蛋白的量来评估 PM 分离和消化方案。
与通过提取试剂盒分离的 PM 样品相比(Bcrp9.8 fmol/μg 蛋白),Potter-Elvehjem 匀浆器与蔗糖垫超速离心联合 Tween 40 对鼠肝进行匀浆以及 PM 富集可使转运蛋白的量增加一倍(Bcrp18.0 fmol/μg 蛋白)。蛋白消化方案的评估表明,PM 蛋白消化最有效的方案是 Lys-C 和胰蛋白酶,结合胰蛋白酶增强剂和热变性。总体而言,通过使用我们优化的 PM 分离方法以及已建立的消化方案评估的鼠肝和肾皮质中的 Bcrp 和 Na+/K+ATPase 蛋白的量比以前报道的要高两到三倍,技术重复的变异系数(CV)低于 10%。
我们通过优化 PM 分离和蛋白消化程序建立了一种改进的转运蛋白定量方法。优化的程序提高了转运蛋白的产量和精密度。